Stilgenbauer, S. Et Al. 2018. Obinutuzumab plus bendamustine in previously untreated patients with CLL: a subgroup analysis of the GREEN study. Leukemia , vol.32, no.8 , 1778-1786.

Stilgenbauer, S., Leblond, V., Foà, R., Böttcher, S., İLHAN, ., Knauf, W., ... Mikuskova, E.(2018). Obinutuzumab plus bendamustine in previously untreated patients with CLL: a subgroup analysis of the GREEN study. Leukemia , vol.32, no.8, 1778-1786.

Stilgenbauer, Stephan Et Al. "Obinutuzumab plus bendamustine in previously untreated patients with CLL: a subgroup analysis of the GREEN study," Leukemia , vol.32, no.8, 1778-1786, 2018

Stilgenbauer, Stephan Et Al. "Obinutuzumab plus bendamustine in previously untreated patients with CLL: a subgroup analysis of the GREEN study." Leukemia , vol.32, no.8, pp.1778-1786, 2018

Stilgenbauer, S. Et Al. (2018) . "Obinutuzumab plus bendamustine in previously untreated patients with CLL: a subgroup analysis of the GREEN study." Leukemia , vol.32, no.8, pp.1778-1786.

@article{article, author={Stephan Stilgenbauer Et Al. }, title={Obinutuzumab plus bendamustine in previously untreated patients with CLL: a subgroup analysis of the GREEN study}, journal={Leukemia}, year=2018, pages={1778-1786} }